期刊文献+

中性粒细胞/淋巴细胞比值及炎症因子在临床诊疗心衰患者中的潜在应用价值

Application value of neutrophil-to-lymphocyte ratio and inflammatory factors in clinical diagnosis and treatment of heart failure patients
下载PDF
导出
摘要 目的探讨心衰患者外周血中性粒细胞/淋巴细胞比值及血清炎症因子IL-6、IL-8在临床诊疗心衰患者中的潜在应用价值。方法选取该院心血管内科2016年12月至2018年3月收治的心衰患者90例为观察组、同期门诊健康体检者90例为对照组,比较两组研究对象血清白细胞介素-8(IL-8)、白细胞介素-6(IL-6)及中性粒细胞/淋巴细胞比值。结果心衰患者血清IL-6、IL-8及中性粒细胞/淋巴细胞比值水平明显高于对照组(P<0.05);此外,死亡患者的血清IL-6、IL-8及中性粒细胞/淋巴细胞比值水平明显高于存活者(P<0.05)。结论心衰患者血清IL-6、IL-8及中性粒细胞/淋巴细胞比值水平均见明显升高,其水平变化对患者的心脏功能评估具有重要实用价值。 Objective To investigate the peripheral blood neutrophil to lymphocyte ratio and serum inflammatory factors IL-6 and IL-8 in patients with heart failure and their potential value in clinical diagnosis and treatment of heart failure.Methods 90 cases with heart failure were selected from December 2016 to February 2018 in our hospital.They were observed in the observation group,and 90 healthy subjects in the same period were randomly selected as the control group.Serum interleukin-8 (IL-8),6 (IL-6) and neutrophil to lymphocyte ratio interleukin-group were compared between the two groups.Results The levels of serum IL-6,IL-8 and neutrophil to lymphocyte in patients with heart failure were significantly higher than those in the control group ( P <0.05).In addition,serum IL-6,IL-8,and neutrophil to lymphocyte ratios were significantly higher in deaths than in survivors (P < 0.05).Conclusion The serum IL-6,IL-8 and neutrophil to lymphocyte ratios in cases with heart failure are significantly increased,and their level changes have important practical value for assessment of cardiac function.
作者 陈占国 张敦憨 CHEN Zhanguo;ZHANG Dunhan(Department of Laboratory,Funing District Hospitalof Qinhuangdao City,066300,China;Department of Gardiology,Funing District Hospitalof Qinhuangdao City,066300,China)
出处 《国际检验医学杂志》 CAS 2019年第A01期138-140,共3页 International Journal of Laboratory Medicine
关键词 心力衰竭 IL-6 IL-8 中性粒细胞/淋巴细胞比值 心脏功能 heart failure IL-6 IL-8 neutrophil to lymphocyte ratio cardiac function
  • 相关文献

参考文献7

二级参考文献53

  • 1Gullestad L, Ueland T, Vinge LE, et al. Inflammatory cyto- kines in heart failure mediators and markers [J]. Cardiology,2012, 122 (I), 23-35.
  • 2Uthamalingam S, Patvardhan EA, Subramanian S, eta|. Utility of the neutrophil to lymphocyte ratio in predicting long- term outcomes in acute decompensated heart failure [J]. Am J Car- diol, 2011, 107 (3): 433-438.
  • 3Williams ES, Shah SJ, Ali S, et al. C- reactive protein, dias- tolic dysfunction, and risk of heart failure in patients with coro- nary disease: Heart and Soul Study [J]. Eur J Heart Fail, 2008, 10 (1): 63-69.
  • 4Smith JG, Newton-Cheh C, Almgren P, et al. Assessment of conventional cardiovascular risk factors and multiple biomar- kers for the prediction of incident heart failure and atrial fibril- lation [J]. J Am Coil Cardiol, 2010, 56 (21) : 1712- 1719.
  • 5Koller L, Kleber M, Goliasch G, et al. C-reactive protein predicts mortality in patients referred for coronary angiography and symptoms of heart failure with preserved ejection fraction [J]. EurJ Heart Fail, 2014, 16 (7): 758-766.
  • 6Kalogeropoulos AP, Tang WH, Hsu A, et al. High-sensitivity C-reactive protein in acute heart failure: insights from the AS- CEND-HFtrial [J]. J Cardiac Fail, 2014, 20: 319-326.
  • 7Jonathan D. Windram, BSc (Hons), MBChB, et al. Rela- :ionship of high-sensitivity C - reactive protein to prognosis and )ther prognostic markers in outpatients with heart failure [J]. m Heart J, 2007, 153 (6): 1048-1055.
  • 8Han YC, Yang TH, Kim DI, et al. Neutrophil to lymphocyte ratio predicts long - term clinical outcomes in patients with ST - segment elevation myocardial infarction undergoing primary percutaneous coronary intervention [J]. Korean Circ J, 2013, 43 (2): 93-99.
  • 9Azab B, Zaher M, Weiserbs KF, et al. Usefulness of neutro- phil to lymphocyte ratio in pedicting short-and long-term mor- tality after non-ST-elevation myocardial infarction [J]. Am J Cardial, 2010, 106 (4): 470-476.
  • 10Arruda-Olson AM, Reeder GS, Bell MR, et al. Neutrophilia predicts death and heart failure after myocardial infarction A community based study [J]. Circ Cardiovasc Qual Outcomes, 2009, 2 (6): 656-662.

共引文献88

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部